Publication
Article
Supplements and Featured Publications
The American Journal of Managed Care
This supplement to includes information on how anxiety disorders will affect the 21st century. This program has been peer reviewed by experts in the field.
Faculty
Evelyn Chiao, PharmD
Applied Health Outcomes
Professor of Psychiatry & Behavioral Sciences
Charleston, South Carolina
Michael T. Eaddy, PharmD, PhD
Applied Health Outcomes
Consultant
Palm Harbor, Florida
Matthew S. Keene, MD
Scottsdale Center for the Advancement of Neuroscience
Consultant
Palm Harbor, Florida
Robert P. Mauch, Jr, PharmD, PhD
Applied Health Outcomes
Consultant
Palm Harbor, Florida
Patt Ellen Panzer, MD, MPH
Blue Cross Blue Shield of Delaware
Timothy S. Regan, BPharm, RPh, CPh
Applied Health Outcomes
Senior Manager
Palm Harbor, Florida
Manan B. Shah, PharmD, PhD
Applied Health Outcomes
Professor of Psychiatry
University of South Florida
Tampa, Florida
Faculty Disclosure
The American Journal of Managed Care
It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.
These participants report relationships with the following pharmaceutical companies:
Consultant to:
Grant support from:
Advisor to:
Consultant/advisor to:
Grant/research support from:
This participant reported no financial affiliations.
GlaxoSmithKline provided funding to Applied Health Outcomes to perform research and development related to this manuscript. The following authors are employed by Applied Health Outcomes.
The following authors received an honorarium from Applied Health Outcomes, which receives grant support from GlaxoSmithKline and other pharmaceutical companies.
The American Journal of Managed Care,
Signed disclosures are on file at the offices of Jamesburg, New Jersey.
This supplement has been supported by funding from GlaxoSmithKline.
---
The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.